Search
Ardent Health Partners Inc
ARDTAdd to Watchlist
17.300USD
+1.400+8.81%
Close 11-06 16:00（ET）
2.44BMarket Cap
18.10P/E TTM
Pre-market 05:51 (ET)17.960USD+0.660+3.81%
Pre-market 05:51 (ET)Ardent Health Partners Inc (ARDT) Stock Price Target & Forecast
Analyst Rating
Based on 13 analysts giving stock ratings to Ardent Health Partners Inc in the past month.
Buy
3 Strong Buy
4 Buy
5 Hold
1 Sell
0 Strong Sell
Target Price
12.727USD+5.80%
ARDT Analyst Recommendation Trends
In the current month, ARDT has received 4 Buy Ratings, 5 Hold Ratings, and 1 Sell Ratings. ARDT average Analyst price target in the last month is 12.727.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
3
3
3
3
3
3
3
3
4
4
4
4
4
4
5
5
5
5
4
4
4
4
4
4
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
13
13
12
12
12
12
13
13
ARDT Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
CVS Health Corp
CVS
7
18
3
0
0
28
HCA Healthcare Inc
HCA
5
10
11
1
0
27
Natera Inc
NTRA
10
13
2
0
0
25
Tenet Healthcare Corp
THC
5
15
4
0
0
24
Teladoc Health Inc
TDOC
2
3
18
0
0
23
Universal Health Services Inc
UHS
2
4
14
1
0
21
Quest Diagnostics Inc
DGX
5
5
9
0
0
19
Labcorp Holdings Inc
LH
6
8
5
0
0
19
Brightspring Health Services Inc
BTSG
7
12
0
0
0
19
Privia Health Group Inc
PRVA
5
12
1
0
0
18
Financial Forecasting
Based on analysts' estimates, ARDT EPS is projected to reach 0.325 in FY2026Q4, following reported EPS of 0.317 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
0.18
0.18
0.22
0.32
0.28
Actual
0.28
0.12
0.32
--
--
Surprise
+52.73%
-34.18%
+46.32%
--
--
FAQs
What is Ardent Health Partners Inc's expected revenue for the next quarter?
Ardent Health Partners Inc's expected revenue is 1.63B.
What is Ardent Health Partners Inc's price target?
Analysts forecast that Ardent Health Partners Inc's price target is USD 12.86, with the highest forecast at USD 14.00 and the lowest forecast at USD 11.00.
How have Ardent Health Partners IncARDT's recent earnings per share performed?
The market expectation was USD 0.32, while Ardent Health Partners IncARDT's earnings per share (EPS) for the previous quarter was USD 0.12. EPS for the next quarter is expected at USD 0.32.
What is the analyst rating for Ardent Health Partners Inc?
Based on the ratings of Ardent Health Partners Inc's stock from 13 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.